Back to Diagnostic Members (DG)
Bioscience Company Member
Organization Overview
ImmunArray is in the process of developing its first product family of blood tests for screening, detection and monitoring of autoimmune diseases and transplant rejection. The company is also developing a novel set of markers of traumatic brain injury, both as standalone acute care tests and as iCHIP components to monitor for the emergence of chronic sequelae of traumatic brain injury.
